X T L Biopharmaceuticals reported $14.7M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 7M 2M Mar/2026
Bioline Rx USD 278M 244M Jul/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
X T L Biopharmaceuticals USD 22M 8M Dec/2024